The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Sirt1 acts in association with PPAR to protect the heart from hypertrophy, metabolic dysregulation, and inflammation
Abstract
AIMS: A complex set of metabolic and inflammatory processes are involved in the development of cardiac hypertrophy. Accumulating evidence indicates an important role for Sirt1 in cardiac function, whereas peroxisome proliferator-activated receptor-α (PPARα) is a master controller of cardiac lipid metabolism and plays a protective role on cardiac hypertrophy. The objective of the present study was to explore the relationships between Sirt1 and PPARα in the control of hypertrophy, metabolism, and inflammation processes in the heart. METHODS AND RESULTS: Neonatal cardiomyocytes (NCMs) were used for studies in vitro. Both the activation of Sirt1 with resveratrol (RSV) and overexpression of Sirt1 inhibited phenylephrine (PE)-induced NCM hypertrophy and prevented PE-induced down-regulation of fatty acid oxidation genes. Sirt1 also inhibited the PE-induced increase in mRNA levels of the pro-inflammatory cytokine monocyte chemoattractant protein-1 in NCMs and blocked the enhanced nuclear factor-κB (NF-κB) activity associated with exposure to PE. Importantly, inhibition of PPARα suppressed the beneficial effects of Sirt1 on hypertrophy, fatty acid metabolism, and inflammation. Co-immunoprecipitation studies revealed that overexpression of Sirt1 enhanced PPARα binding to the p65 subunit of NF-κB and led to p65-deacetylation in NCMs. Moreover, Sirt1 overexpression led to the deacetylation of the PPARα co-activator PGC-1α. Consistent with these observations in vitro, isoproterenol-induced cardiac hypertrophy, metabolic dysregulation, and inflammation in vivo were prevented by RSV in wild-type mice but not in PPARα-null mice. CONCLUSIONS: Collectively, these findings reveal a major involvement of the Sirt1-PPARα interaction in the protective role of Sirt1 against cardiac hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
Gerhart‐Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S., Mostoslavsky, R., Alt, F. W., Wu, Z., & Puigserver, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601633 · Cited by 1,294
Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., & Li, X. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.006 · Cited by 1,003
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
A novel mouse model of lipotoxic cardiomyopathy
Chiu, H.-C., Kovacs, A., Ford, D. A., Hsu, F.-F., Garcia, R., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10947 · Cited by 760
Sirtuins as potential targets for metabolic syndrome
Guarente, L. (2006) · Nature · doi:10.1038/nature05486 · Cited by 468
SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes
Yoshizaki, T., Milne, J. C., Imamura, T., Schenk, S., Sonoda, N., Babendure, J. L., Lu, J.-C., Smith, J. J., Jirousek, M. R., & Olefsky, J. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00705-08 · Cited by 415
Hirotani, S., Otsu, K., Nishida, K., Higuchi, Y., Morita, T., Nakayama, H., Yamaguchi, O., Mano, T., Matsumura, Y., Ueno, H., et al. (2002) · Circulation · doi:10.1161/hc0402.102863 · Cited by 360
Lee, J.-H., Song, M.-Y., Song, E.-K., Kim, E.-K., Moon, W. S., Han, M.-K., Park, J.-W., Kwon, K.-B., & Park, B.-H. (2009) · Diabetes · doi:10.2337/db07-1795 · Cited by 346
de Vries, J. E., Vork, M. M., Roemen, T. H., de Jong, Y. F., Cleutjens, J. P., van der Vusse, G. J., & van Bilsen, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37421-6 · Cited by 324
Purcell, N. H., Tang, G., Yu, C., Mercurio, F., DiDonato, J. A., & Lin, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111155798 · Cited by 323
Requirement for the heart‐type fatty acid binding protein in cardiac fatty acid utilization
Binas, B., Danneberg, H., Mcwhir, J., Mullins, L., & Clark, A. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.805 · Cited by 314
Alcendor, R. R., Kirshenbaum, L. A., Imai, S.-I., Vatner, S. F., & Sadoshima, J. (2004) · Circulation Research · doi:10.1161/01.res.0000147557.75257.ff · Cited by 303
Effects of moderate hypertension on cardiac function and metabolism in the rabbit.
Taegtmeyer, H., & Overturf, M. L. (1988) · Hypertension · doi:10.1161/01.hyp.11.5.416 · Cited by 236
Amat, R., Planavila, A., Chen, S. L., Iglesias, R., Giralt, M., & Villarroya, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022749 · Cited by 218
Self-citationHiguchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O., Matsumura, Y., Ueno, H., Tada, M., & Hori, M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1505 · Cited by 192
The role of chemokines in human cardiovascular pathology: enhanced biological insights
Shin, W. S., Szuba, A., & Rockson, S. G. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00571-8 · Cited by 190
PLANAVILA, A., RODRIGUEZCALVO, R., JOVE, M., MICHALIK, L., WAHLI, W., LAGUNA, J., & VAZQUEZCARRERA, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.011 · Cited by 173
Self-citationThandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., Kopilas, M. A., Anderson, H. D., & Netticadan, T. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.228 · Cited by 172
NF-κB activation is required for the development of cardiac hypertrophy in vivo
Li, Y., Ha, T., Gao, X., Kelley, J., Williams, D. L., Browder, I. W., Kao, R. L., & Li, C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00124.2004 · Cited by 170
Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophy
Gupta, S., Purcell, N. H., Lin, A., & Sen, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200207149 · Cited by 142
Planavila, A., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414220200 · Cited by 129
Self-citationSmeets, P., Teunissen, B. E. J., Planavila, A., den Bosch, H. D. V.-V., Willemsen, P. H. M., Vusse, G. J., & van Bilsen, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802143200 · Cited by 120
Self-citationBiala, A., Tauriainen, E., Siltanen, A., Shi, J., Merasto, S., Louhelainen, M., Martonen, E., Finckenberg, P., Muller, D. N., & Mervaala, E. (2010) · Blood Pressure · doi:10.3109/08037051.2010.481808 · Cited by 97 · cited 1×
“The direct or indirect effect of RSV on Sirt1 activation is controversial,(21) but a recent study showed a direct dose-dependent increase in Sirt1 activity elicited by RSV in cardiomyocytes.(22) The same authors demonstrated the protective role of RSV on angiotensin II-induced cardiovascular damage.”
BackgroundTranscriptional regulation of metabolic processes: implications for cardiac metabolism
van Bilsen, M., Vusse, G. J., & Reneman, R. S. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050739 · Cited by 85
Wojciechowski, P. W., Juric, D., Louis, X. L., Thandapilly, S. J., Yu, L., Taylor, C. G., & Netticadan, T. (2010) · Journal of Nutrition · doi:10.3945/jn.109.115006 · Cited by 83
Liang, F., Wang, F., Zhang, S., & Gardner, D. G. (2003) · Endocrinology · doi:10.1210/en.2002-0217 · Cited by 76
SirT1 in muscle physiology and disease: lessons from mouse models
Vinciguerra, M., Fulco, M., Ladurner, A. G., Sartorelli, V., & Rosenthal, N. A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004655 · Cited by 70
Cited by
SIRT1 and other sirtuins in metabolism
Chang, H.-C., & Guarente, L. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.12.001 · Cited by 1,133
Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., & Salminen, A. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.007 · Cited by 989
Regulation of SIRT1 and Its Roles in Inflammation
Yang, Y., Liu, Y., Wang, Y., Chao, Y., Zhang, J., Jia, Y., Tie, J., & Hu, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831168 · Cited by 690
PPARs at the crossroads of lipid signaling and inflammation
Wahli, W., & Michalik, L. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.001 · Cited by 675
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
“Moreover, activation of Sirt1 through caloric restriction induces PGC-1α activity and enhances mitochondrial function (Planavila et al., 2011; Tang, 2016).”
Background
Metadata
- Authors
- Planavila, A., Iglesias, R., Giralt, M., & Villarroya, F.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-29
- Volume
- 90
- Issue
- 2
- Pages
- 276-284
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W1979657807
- Cited by
- 317
- References
- 34
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.